In analogy to MNT-1 melanoma cells reported previously19, KO of TPC2 in SK-MEL-5 cells showed reduction in migration, invasion, and proliferation in all three CRISPR/Cas9 engineered TPC2 KO lines (Fig. 4a–e). The gene discussed is TPCN2; the disease is melanoma.